Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 45 - 84 |
| Updated: | 4/17/2018 |
| Start Date: | October 2012 |
| End Date: | January 2018 |
A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent® for Lowering Intraocular Pressure in Primary Open Angle Glaucoma
This clinical trial compares two implantable devices intended to lower the pressure inside
the eye of glaucoma patients.
the eye of glaucoma patients.
This is a prospective, multicenter, single-masked, randomized clinical trial comparing the
Hydrus Microstent to two iStent implants for the reduction of intraocular pressure in phakic
patients with a positive diagnosis of primary open angle glaucoma, pseudoexfoliative
glaucoma, or pigmentary dispersion glaucoma. Post-operative follow-up visits will be
conducted at regular intervals.
Hydrus Microstent to two iStent implants for the reduction of intraocular pressure in phakic
patients with a positive diagnosis of primary open angle glaucoma, pseudoexfoliative
glaucoma, or pigmentary dispersion glaucoma. Post-operative follow-up visits will be
conducted at regular intervals.
Inclusion Criteria:
- A diagnosis of primary open angle glaucoma (POAG), Pseudoexfoliative (PXG) glaucoma,
or Pigmentary glaucoma (PG)
- A phakic lens with BCVA of 20/30 or better
Exclusion Criteria:
- Forms of primary or secondary glaucoma not listed above
- Prior glaucoma surgery in the study eye
We found this trial at
1
site
Click here to add this to my saved trials
